Skip to content
Search

Latest Stories

DHSC releases final drug price concessions list for May 2020

Department of Health and Social Care (DHSC) has released final drug price concessions list for May 2020 on Friday (May 29).

The new additions to the May 2020 price concession list are below.


DrugPack sizePrice Concession
Carbocisteine 375mg capsules120£6.87
Clarithromycin 250mg/5ml oral suspension70ml£8.60
Clonidine 25microgram tablets112£13.62
Duloxetine 20mg gastro-resistant capsules28£5.17
Duloxetine 40mg gastro-resistant capsules56£12.09
Erythromycin 250mg gastro-resistant tablets28£7.37
Exemestane 25mg tablets30£61.57
Fenofibrate micronised 267mg capsules28£4.51
Glycopyrronium bromide 200micrograms/1ml solution for injection ampoules10£14.00
Mirtazapine 15mg orodispersible tablets30£1.97
Mirtazapine 45mg tablets28£3.10
Mometasone 50micrograms/dose nasal spray140 dose£4.99
Nitrofurantoin 50mg tablets28£14.04
Ranitidine 300mg tablets30£5.99
Ranitidine 50mg/2ml solution for injection ampoules5£49.00
Rasagiline 1mg tablets28£5.17
Senna 7.5mg/5ml oral solution sugar free500ml£12.93

DHSC previously announced price concessions for the following drugs on May 20.

DrugPack sizePrice Concession
Aciclovir 400mg tablets56£3.44
Aciclovir 800mg tablets35£4.65
Amiloride 5mg tablets28£24.50
Amiodarone 200mg tablets28£2.90
Azathioprine 25mg tablets28£4.55
Azathioprine 50mg tablets56£5.30
Betahistine 16mg tablets84£5.00
Clarithromycin 125mg/5ml oral suspension70ml£3.69
Co-careldopa 25mg/100mg tablets100ml£16.18
Diamorphine 10mg powder for solution for injection ampoules5£16.56
Donepezil 10mg tablets28£2.80
Esomeprazole 20mg gastro-resistant capsules28£2.30
Esomeprazole 40mg gastro-resistant capsules28£2.75
Estradiol 1mg tablets84£6.89
Estradiol 2mg tablets84£6.89
Ezetimibe 10mg tablets28£3.10
Gabapentin 600mg tablets100£14.21
Hydroxychloroquine 200mg tablets60£7.39
Hydroxyzine 10mg tablets84£1.93
Ibuprofen 400mg tablets24£1.56
Ibuprofen 400mg tablets84£5.45
Imipramine 25mg tablets28£5.65
Irbesartan 150mg tablets28£8.84
Irbesartan 300mg tablets28£4.78
Lamotrigine 100mg dispersible tablets sugar free56£8.95
Lamotrigine 25mg dispersible tablets sugar free56£5.30
Lymecycline 408mg capsules28£6.60
Meloxicam 15mg tablets30£5.40
Meloxicam 7.5mg tablets30£3.15
Metoclopramide 10mg tablets28£1.21
Metronidazole 400mg tablets21£5.15
Mometasone 0.1% cream30g£3.48
Montelukast 10mg tablets28£3.15
Naftidrofuryl 100mg capsules84£6.49
Naproxen 250mg tablets28£3.10
Naproxen 500mg tablets28£2.91
Nitrazepam 5mg tablets28£5.51
Olmesartan medoxomil 10mg tablets28£2.00
Oxytetracycline 250mg tablets28£4.99
Perindopril erbumine 2mg tablets30£2.80
Perindopril erbumine 4mg tablets30£4.50
Perindopril erbumine 8mg tablets30£4.80
Pizotifen 1.5mg tablets28£4.99
Pseudoephedrine hydrochloride 60mg tablets100£9.38
Quetiapine 100mg tablets60£4.19
Quinine bisulfate 300mg tablets28£6.99
Quinine sulfate 300mg tablets28£6.50
Rosuvastatin 20mg tablets28£2.22
Sertraline 100mg tablets28£14.32
Sertraline 50mg tablets28£8.50
Sulpiride 200mg tablets30£7.53
Tacrolimus 0.1% ointment30g£25.92
Tacrolimus 0.1% ointment60g£45.99
Tamoxifen 20mg tablets30£5.43
Tetracycline 250mg tablets28£5.08
Tolterodine 1mg tablets56£20.93
Tolterodine 2mg tablets56£19.86
Tranexamic acid 500mg tablets60£8.36
Trihexyphenidyl 2mg tablets84£8.29
Trimethoprim 50mg/5ml oral suspension sugar free100ml£4.99
Valaciclovir 500mg tablets10£20.59
Venlafaxine 37.5mg tablets56£4.75
Venlafaxine 75mg tablets56£11.67

No additional endorsements are required for price concessions. The above price concessions only apply to prescriptions submitted for payment in May 2020.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less